TLP
GILD icon

Trinity Legacy Partners’s Gilead Sciences GILD Stock Holding History

Trinity Legacy Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-39,568
Closed -$2.55M – 99
2020
Q3 		$2.55M Buy
39,568
+703
+2% +$48.8K 1.23% 26
2020
Q2 		$2.98M Buy
38,865
+757
+2% +$58K 1.53% 19
2020
Q1 		$2.93M Buy
38,108
+33,093
+660% +$2.29M 2.07% 16
2019
Q4 		$330K Buy
+5,015
New +$327K 0.15% 67

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Trinity Legacy Partners's GILD Position: Q4 2020 in Review

Trinity Legacy Partners sold out of Gilead Sciences (GILD) in Q4 2020, closing a stake of 39,568 shares — an estimated $2.55M sold.

Trinity Legacy Partners first reported a position in GILD in Q4 2019 and held it in 4 quarters. The position peaked at $2.98M in Q2 2020. 1,563 funds tracked by Wall St. Rank hold GILD as of Q4 2020.

  • Trinity Legacy Partners reported no remaining Gilead Sciences position as of Q4 2020 after selling out during the quarter.
  • Trinity Legacy Partners sold 39,568 Gilead Sciences shares in Q4 2020, an estimated $2.55M.
  • Trinity Legacy Partners first reported a position in Gilead Sciences in Q4 2019 and held it in 4 quarters.
  • Trinity Legacy Partners's Gilead Sciences position peaked at $2.98M in Q2 2020.
  • 1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2020.

Based on Trinity Legacy Partners's 13F filing for Q4 2020, filed 20 Jan 2021.